Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Veterinary Clinical, Anatomical, and Comparative Pathology

Volume 12 - 2025 | doi: 10.3389/fvets.2025.1638459

This article is part of the Research TopicInnovative Approaches in Veterinary Pathology: Diagnostics, Therapeutics, and Zoonotic ThreatsView all 13 articles

Histological and immunohistochemical characterization of granulomas in alpacas (Vicugna pacos) naturally infected with tuberculosis

Provisionally accepted
  • 1Universidad de Cordoba Facultad de Veterinaria, Córdoba, Spain
  • 2UK Health Security Agency Porton, Salisbury, United Kingdom
  • 3School of Veterinary Medicine. Department of Pathology and Infectious Diseases, UK Health Security Agency (UKHSA), London, United Kingdom
  • 4Camelid Veterinary Services Ltd, Reading, United Kingdom

The final, formatted version of the article will be published soon.

Tuberculosis (TB), caused by the Mycobacterium tuberculosis complex (MTBC), is a chronic zoonotic disease of increasing concern in alpacas (Vicugna pacos), a species highly susceptible to the disease. Given the growing alpaca population in Europe and documented zoonotic infection in humanszoonotic potential, understanding TB pathology in alpacas is crucial. This study provides the first comprehensive histopathological and immunohistochemical characterization of TB lesions in naturally infected alpacas. Granulomas from the lungs (n=175), liver (n=241),, and lymph nodes (n=55), were classified into four developmental stages (I, II, III and IV) based on their morphology, necrosis, fibrosis, cellular composition, and presence of acid-fast bacilli (AFBs). Advanced granulomas (stages III and IV) predominated in all tissues, indicating chronic infection. High numbers of AFBs were observed in lung and lymph node granulomas across all stages, with very rare presence of multinucleated giant cells (MNGCs)., with numbers increasing as lesions progressed in the lungs. This pattern in the lung, with extensive necrosis and lack of fibrous encapsulation, together with the presence of abundant AFBs, suggests deficient immune control and significant transmission risk. In contrast, liver granulomas, particularly encapsulated stage IV lesions, showed fewer detectable AFBs, implying better mycobacterial control in this organ. Immunohistochemistry in selected granulomas revealed ionized calcium-dinding adaptor protecin macrophages (IBA1+) immunopositive macrophages were most prevalent cells in early stages (stage I and II) , while T (CD3+) and B lymphocytes (B-cell SAPspecific activator protecin+) increased in advanced (stage III and IV) granulomas, forming peripheral lymphoid follicle-like structures. Neutrophils (MPOimmunopositve to myeloperoxidase+) were less abundant, but more prominent in advanced lesions showing extensive necrosis. The high incidence of liver lesions suggests the oral route as a notable infection pathwayhigh dissemination of pathogenic mycobacteria and generalised tuberculosis in this species. This research fills knowledge gaps about TB tuberculous granulomas in camelids and highlights alpacas as potential sources of mycobacterial excretion, posing a transmission risk to domestic animals, wildlife, and humans.

Keywords: Tuberculosis, Alpacas, Granuloma, Immunohistochemistry, Cell marker, Mycobacterium tuberculosis complex

Received: 30 May 2025; Accepted: 02 Sep 2025.

Copyright: © 2025 Agullo-Ros, RUEDAS TORRES, Hunter, Bird, Whitehead and Salguero. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Francisco Javier Salguero, School of Veterinary Medicine. Department of Pathology and Infectious Diseases, UK Health Security Agency (UKHSA), London, GU2 7TE, United Kingdom

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.